U44, SB1, applications applications VA UB1 other than unless the Phase I and not phase 1 is for applying to DOE DOE Have you N N NIH, Incl: R43, Provide error if Company E New Rule received R44, U43, Company SBIR history is October 2017 Phase II Release (NIH) FDA, history is not required, if your awards provided when response to the from the response to the question, “Have Federal VA question, Have you received “ you receive SBIR Phase II SBIR Phase II awards from the Company awards from the Federal Federal is Government?” is Government” “Yes”. History “Yes”. Will the N N NIH, Incl: R43, Provide error if You have E New Rule Project R44, U43, response to selected “SBIR” U44 ,SB1, question , or as your October 2017 “Will “Both” Release (NIH) FDA, UB1 the Project program Type. You must have Investigator provide a his/her VA have his/her response to the primary primary question, “Will with the employment with the Project small
VA U44, SB1, UB1 applications other than Phase I and not applying to DOE applications unless the phase 1 is for DOE (NIH) Have you received SBIR Phase II awards from the Federal Company History N N NIH, FDA, VA Incl: R43, R44, U43, Provide error if Company history is not provided when response to the question, “ Have you receive SBIR Phase II awards from the Federal Government” is “Yes”. Company history is required, if your response to the question, “Have you received SBIR Phase II awards from the Federal Government?” is “Yes”. E New Rule October 2017 Release (NIH) Will the Project have his/her primary with the small N N NIH, FDA, VA Incl: R43, R44, U43, U44 ,SB1, UB1 Provide error if response to question , “Will the Project Investigator have his/her primary employment with You have selected “SBIR” or “Both” as your program Type. You must provide a response to the question, “Will the Project E New Rule October 2017 Release